SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-094741
Filing Date
2010-10-21
Accepted
2010-10-21 08:15:54
Documents
3
Period of Report
2010-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c07126e8vk.htm 8-K 14203
2 EXHIBIT 99.1 c07126exv99w1.htm EX-99.1 7920
3 GRAPHIC c07126p0712601.jpg GRAPHIC 9637
  Complete submission text file 0000950123-10-094741.txt   37311
Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52998 | Film No.: 101134112
SIC: 2834 Pharmaceutical Preparations